6505-01-503-4772 Moxifloxacin hydrochloride table
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $135.74 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 2
- Awards on record
- 102
- 2014 to 2026
- DLA demand
- –
Identification
- Item name
- Moxifloxacin hydrochloride table
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 18-DEC-02
- Unit
- BT
- NSN
- 6505-01-503-4772
- NIIN
- 01-503-4772
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00093-7387-56 | DLA approved-source file |
| RISING PHARMA HOLDINGS, INC. | 8FG82 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC57237-0156-30 | DLA approved-source file |
| 4N221 | R (Cancelled company discontinued) | 3 (Design control reference) / 9 (Was the design control reference) | NDC00085-1733-01 | FLIS part list | |
| 4E8M8 | A (Active) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC55111-0112-30 | FLIS part list | |
| 4N221 | R (Cancelled company discontinued) | 5 (Secondary reference) / 9 (Was the design control reference) | AVELOX | FLIS part list | |
| 89875 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 02-2805 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
1 contract DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 6 | December 13, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| AJUC | American hospital formulary service classification number | 081218 |
| CXCY | Part name assigned by controlling agency | MOXIFLOXACIN HCL 400 MG TABLET 30S BT |
| FEAT | Special features | 400MG. MOXIFLOXACIN ACTIVE INGREDIENT; BOTTLE OF 30 TABLETS; USED TO TREAT LUNG , SINUS OR SKIN INFECTIONS CAUSED FROM BACTERIA; STORE AT CONTROLLED ROOM TEMPERATURE; AVOID HIGH HUMIDITY |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- PINC
- 1821124
- Criticality (CRIT CD)
- X
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| VP01 | Peru (VP) | ||||||
| ZW01 | Turkey (ZW) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $130.22 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $130.22 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $130.22 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $135.74 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Level A
- Z (Special requirement)
- Level B
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0316DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 28 | BT | $135.74 per BT | … | … | No set-aside | No | November 12, 2026 | November 18, 20265 days left |
| SPE2DP27T0154DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 4 | BT | $135.74 per BT | … | … | No set-aside | No | October 25, 2026 | November 2, 2026Closed |
| SPE2DP27T0127DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 3 | BT | $135.74 per BT | … | … | No set-aside | No | October 19, 2026 | October 26, 2026Closed |
| SPE2DP27T0079DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 60 | BT | $135.74 per BT | … | … | No set-aside | No | October 8, 2026 | October 14, 2026Closed |
| SPE2DP26T5291DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 67 | BT | $135.74 per BT | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed | |
| SPE2DP26T3502DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 17 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | May 26, 2026Closed | |
| SPE2DP26T4509DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 8 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | August 11, 2026Closed | |
| SPE2DP26T4616DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 9 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | August 17, 2026Closed | |
| SPE2DP26T4755DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 12 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | August 31, 2026Closed | |
| SPE2DP26T4798DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 124 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | September 8, 2026Closed | |
| SPE2DP26T5052DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 15 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | September 21, 2026Closed | |
| SPE2DP26T5159DIBBS only | 6505-01-503-4772 | Moxifloxacin hydrochloride table | 12 | BT | $135.74 per BT | … | … | No set-aside | November 3, 2026First seen | September 23, 2026Closed |
Showing 1 to 10 of 12 results
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 90 days, production 120 days (210 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
102 award lines since 2014, 10 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 37 | February 2, 2020 |
| 0AG09SZY HOLDINGS, LLC | 31 | October 20, 2026 |
| 3W8H0MR UNLIMITED, LLC | 12 | September 28, 2026 |
| 49KA0ASE DIRECT, INC. | 6 | December 7, 2023 |
| 8H3Q8OAKRIDGE DYNAMICS LLC | 5 | October 6, 2026 |
| 1KA59ARS SALES & SERVICES LLC | 4 | November 25, 2025 |
| 82CP7SCOT-MED LLC | 3 | November 26, 2025 |
| 7R5V7THE STRONGHOLD GROUP LLC | 2 | October 23, 2025 |
| 66RP4CORE TRADING CO | 1 | May 13, 2026 |
| 00E55Cardinal Health, Inc. | 1 | March 30, 2017 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 11 | 4 |
| 2025 | 20 | 6 |
| 2024 | 12 | 2 |
| 2023 | 7 | 3 |
| 2022 | 9 | 2 |
| 2021 | 1 | 1 |
| 2020 | 6 | 2 |
| 2019 | 1 | 1 |
| 2018 | 6 | 1 |
| 2017 | 7 | 2 |
| 2016 | 13 | 1 |
| 2015 | 4 | 1 |
| 2014 | 5 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | CARDINAL HEALTH, INC. | $2,848,913 | 1 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $750,838 | 27 |
| 3 | SZY HOLDINGS, LLC | $37,918 | 26 |
| 4 | MR UNLIMITED, LLC | $13,474 | 11 |
| 5 | SCOT-MED LLC | $12,983 | 3 |
| 6 | THE STRONGHOLD GROUP LLC | $6,975 | 2 |
| 7 | CORE TRADING CO | $2,995 | 1 |
| 8 | OAKRIDGE DYNAMICS LLC | $1,836 | 1 |
| 9 | ARS SALES & SERVICES LLC | $1,624 | 4 |
| 10 | ASE DIRECT, INC. | $546 | 6 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26P0810From the item's award history | May 13, 2026 | CORE TRADING CO | $2,995 |
| SPE2DP26V0195From the item's award history | November 26, 2025 | SCOT-MED LLC | $2,204 |
| SPE2DP26V0191From the item's award history | November 25, 2025 | ARS SALES & SERVICES LLC | $792 |
| SPE2DP26V0193From the item's award history | November 25, 2025 | ARS SALES & SERVICES LLC | $335 |
| SPE2DP26V0188From the item's award history | November 24, 2025 | ARS SALES & SERVICES LLC | $335 |
| SPE2DP26V0181From the item's award history | November 19, 2025 | OAKRIDGE DYNAMICS LLC | $1,836 |
| SPE2DP26V0110From the item's award history | October 27, 2025 | SCOT-MED LLC | $8,024 |
| SPE2DP26V0111From the item's award history | October 27, 2025 | SCOT-MED LLC | $2,755 |
| SPE2DP26P0093From the item's award history | October 23, 2025 | THE STRONGHOLD GROUP LLC | $225 |
| SPE2DP25V3705From the item's award history | September 16, 2025 | SZY HOLDINGS, LLC | $158 |
| SPE2DP25P0717From the item's award history | September 15, 2025 | THE STRONGHOLD GROUP LLC | $6,750 |
| SPE2DP25V3529From the item's award history | September 2, 2025 | MR UNLIMITED, LLC | $1,096 |
| SPE2DP25V3516From the item's award history | August 29, 2025 | MR UNLIMITED, LLC | $969 |
| SPE2DP25V3432From the item's award history | August 20, 2025 | SZY HOLDINGS, LLC | $176 |
| SPE2DP25V3298From the item's award history | August 12, 2025 | SZY HOLDINGS, LLC | $440 |
| SPE2DP25V3030From the item's award history | July 23, 2025 | MR UNLIMITED, LLC | $454 |
| SPE2DP25V2841From the item's award history | July 8, 2025 | SZY HOLDINGS, LLC | $184 |
| SPE2DP25V2032From the item's award history | May 9, 2025 | SZY HOLDINGS, LLC | $8,590 |
| SPE2DP25V1968From the item's award history | May 5, 2025 | SZY HOLDINGS, LLC | $2,834 |
| SPE2DP25V1385From the item's award history | March 14, 2025 | SZY HOLDINGS, LLC | $192 |
| SPE2DP25V1043From the item's award history | February 18, 2025 | SZY HOLDINGS, LLC | $1,843 |
| SPE2DP25V0555From the item's award history | December 18, 2024 | SZY HOLDINGS, LLC | $1,879 |
| SPE2DP25V0397From the item's award history | November 26, 2024 | MR UNLIMITED, LLC | $208 |
| SPE2DP25V0358From the item's award history | November 21, 2024 | MR UNLIMITED, LLC | $105 |
| SPE2DP25V0322From the item's award history | November 19, 2024 | SZY HOLDINGS, LLC | $312 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.